pyrimethamine has been researched along with Cushing Syndrome in 1 studies
Maloprim: contains above 2 cpds
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camanni, F | 1 |
| Losana, O | 1 |
| Massara, F | 1 |
| Molinatti, GM | 1 |
1 other study available for pyrimethamine and Cushing Syndrome
| Article | Year |
|---|---|
Increased renal phosphate excretion in Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adult; Cushing Syndrome; Dexamethasone; Female; Humans; Kidne | 1967 |